Johannes van der Vliet — Amsterdam UMC research portal

View Scopus Profile

Research activity per year

External positions

Co-founder and CSO, Lava Therapeutics, Utrecht, The Netherlands

1 Dec 2018 → …

106 Article
15 Review article
2 Chapter
1 Comment/Letter to the editor
More
- 1 Erratum/Corrigendum

A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
Lameris, R., Ruben, J. M., Iglesias-Guimarais, V., de Jong, M., Veth, M., van de Bovenkamp, F. S., de Weerdt, I., Kater, A. P., Zweegman, S., Horbach, S., Riedl, T., Winograd, B., Roovers, R. C., Adang, A. E. P., de Gruijl, T. D., Parren, P. W. H. I. & van der Vliet, H. J., 21 Mar 2023, In: Cell Reports Medicine. 4, 3, p. 100961 100961.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

10 Citations (Scopus)
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors
King, L. A., Toffoli, E. C., Veth, M., Iglesias-Guimarais, V., Slot, M. C., Amsen, D., van de Ven, R., Derks, S., Fransen, M. F., Tuynman, J. B., Riedl, T., Roovers, R. C., Adang, A. E. P., Ruben, J. M., Parren, P. W. H. I., de Gruijl, T. D. & van der Vliet, H. J., 1 Sept 2023, In: Cancer immunology research. 11, 9, p. 1237-1252 16 p.
Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer
Toffoli, E. C., van Vliet, A. A., Verheul, H. W. M., van der Vliet, H. J., Tuynman, J., Spanholtz, J. & de Gruijl, T. D., 6 Dec 2023, In: Journal for Immunotherapy of Cancer. 11, 12, e007554.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions
Lameris, R., Shahine, A., Veth, M., Westerman, B., Godfrey, D. I., Hulsik, D. L., Brouwer, P., Rossjohn, J., de Gruijl, T. D. & van der Vliet, H. J., 1 Dec 2023, In: Journal for Immunotherapy of Cancer. 11, 12, e007631.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

1 Citation (Scopus)
Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort
Doppenberg, D., Lagerwaard, F. J., van Dieren, S., Meijerink, M. R., van der Vliet, J. J., Besselink, M. G., van Tienhoven, G., Versteijne, E., Slotman, B. J., Wilmink, J. W., Kazemier, G. & Bruynzeel, A. M. E., 2023, In: Frontiers in Oncology. 13, 1149961.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

1 Citation (Scopus)